Literature DB >> 9364465

The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related.

J Taylor1, F Muntoni, V Dubowitz, C A Sewry.   

Abstract

Utrophin is a 395 kDa protein with considerable homology to dystrophin. It is highly expressed in the sarcolemma of normal fetal muscle fibres but is confined to neuromuscular and myotendinous junctions, and blood vessels in adult muscle. Sarcolemmal expression occurs on regenerating fibers, irrespective of the disease, and is also seen on mature fibres in Duchenne and Becker muscular dystrophies (DMD, BMD), and inflammatory myopathies. The reasons for the abnormal expression in DMD and BMD are unclear. We have studied this expression of utrophin immunocytochemically on mature fibres in 42 cases of DMD and BMD, aged 3 months-24 years of age. All cases had some mature fibres, with no detectable fetal myosin, that showed sarcolemmal expression of utrophin. The number of these fibers and the intensity of fluorescence was low in young cases before the age of 2 years and increased with age. The fluorescence was graded on a scale of 0 to ++ ++ and there were significantly more cases under 2 years of age (10/12) with a grading of utrophin of only +, compared with those over 2 years (4/30, P < 0.001). Some revertant fibres, but not all, expressed utrophin and dystrophin. Our data show that the abnormal expression of utrophin on mature muscle fibres in DMD and BMD is not a continuation of the expression that occurs in fetal or regenerating muscle, but is a secondary event caused by unknown factors. The immunocytochemical intensity of utrophin is variable between cases and there is no correlation with clinical severity. As all cases studied had some expression of utrophin on mature fibres, this may be a useful additional tool for distinguishing BMD from other dystrophies, especially in cases with minimal abnormalities in dystrophin expression and/or no detectable mutation in the gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364465

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  12 in total

Review 1.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

2.  The effect of respiratory muscle training with CO2 breathing on cellular adaptation of mdx mouse diaphragm.

Authors:  Stefan Matecki; François Rivier; Gerald Hugon; Christelle Koechlin; Alain Michel; Christian Prefaut; Dominique Mornet; Michele Ramonatxo
Journal:  Neuromuscul Disord       Date:  2005-04-18       Impact factor: 4.296

3.  Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice.

Authors:  J Muller; N Vayssiere; M Royuela; M E Leger; A Muller; F Bacou; F Pons; G Hugon; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

4.  Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.

Authors:  Dejia Li; Chun Long; Yongping Yue; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2009-01-08       Impact factor: 6.150

5.  Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function.

Authors:  Yifan Lu; Chai Tian; Gawiyou Danialou; Rénald Gilbert; Basil J Petrof; George Karpati; Josephine Nalbantoglu
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

6.  Upregulation of the creatine synthetic pathway in skeletal muscles of mature mdx mice.

Authors:  Warren C McClure; Rick E Rabon; Hirofumi Ogawa; Brian S Tseng
Journal:  Neuromuscul Disord       Date:  2007-06-27       Impact factor: 4.296

7.  From proteins to genes: immunoanalysis in the diagnosis of muscular dystrophies.

Authors:  Rita Barresi
Journal:  Skelet Muscle       Date:  2011-06-24       Impact factor: 4.912

8.  Muscle structure influences utrophin expression in mdx mice.

Authors:  Glen B Banks; Ariana C Combs; Guy L Odom; Robert J Bloch; Jeffrey S Chamberlain
Journal:  PLoS Genet       Date:  2014-06-12       Impact factor: 5.917

9.  The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.

Authors:  Simon Guiraud; Benjamin Edwards; Arran Babbs; Sarah E Squire; Adam Berg; Lee Moir; Matthew J Wood; Kay E Davies
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

10.  Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.

Authors:  Narinder Janghra; Jennifer E Morgan; Caroline A Sewry; Francis X Wilson; Kay E Davies; Francesco Muntoni; Jonathon Tinsley
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.